Shree Ganesh Remedies Limited
Shree Ganesh Remedies Limited (SGRL): company summary
The company's annual revenue grew 0.6% to ₹109 crore, but net profit fell 23.0% to ₹18 crore.
Shree Ganesh Remedies Limited (SGRL) is a micro-cap Healthcare company valued at ₹888 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Shree Ganesh Remedies Limited last traded at ₹691, modestly up 0.54% on the day.
- Recent developments
- On 2026-06-30, the company reported a sharp decline in both revenue and net profit for the latest quarter compared to the same period a year earlier, raising concerns about its recent operational performance.
- Financial performance
- The company's annual revenue grew 0.6% to ₹109 crore, but net profit fell 23.0% to ₹18 crore. The latest quarter saw revenue drop 41.8% to ₹14 crore and net profit fall 67.5% to ₹1 crore, indicating a significant slowdown in recent performance.
- Valuation multiples
- The stock trades at 50.0 times earnings, a premium to the Healthcare median of 32.0, 5.47 times book value.
- Things to watch
- The company's net profit margin narrowed 5.0 percentage points to 16.3%, and its latest quarter net profit dropped 67.5% from the year-ago period. The stock is 7.7% below its 52-week high, and domestic institutional holding increased by 0.52 points in the quarter.
- Where it stands
- Shree Ganesh Remedies Limited ended the latest quarter with revenue of ₹14 crore and net profit of ₹1 crore, both down significantly from the year-ago period. The company's net profit margin and recent quarterly performance highlight challenges in maintaining profitability.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (8.6) and momentum (7.5), but held back by valuation (0.0). Risk looks strong at 8.6, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.19
- Profitable in all of the last 5 years
- Revenue compounding 17% a year
- Valuation is weak (0.0/10)
- Small ₹888 cr company — thinner liquidity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Shree Ganesh Remedies Limited’s valuation
Free deep-dive tools · no sign-up
Shree Ganesh Remedies Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Shree Ganesh Remedies Limited with peers
Related tools & concepts
Value Shree Ganesh Remedies Limited with the ratios and calculators DocStoX uses in its analysis.

